News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Quantel Medical Inc. Launches Worldwide Clinical Study To Validate Aramis Medical Laser For The Treatment Of Acne



10/19/2005 5:10:12 PM

CLERMONT-FERRAND, France, Nov. 4 /PRNewswire/ -- Quantel Medical, an international market leader in ultrasound and laser systems for Ophthalmology and Dermatology announced today that it is conducting a worldwide clinical study on the Aramis Er:Glass 1.54 micron Laser for its use to treat inflammatory acne. Already approved by the Food and Drug Administration (FDA) for general dermatological use including dermal remodeling and wrinkle reduction, the ongoing study will validate the company's application to the U.S. Food and Drug Administration (FDA) to market the laser in the U.S. for the treatment of acne.

Acne is a disease of the sebaceous gland of the skin and is caused by clogged pores by the increased sebum production and the presence of bacteria. This leads to a thickening or inflammation of the lining of the follicle, resulting in less severe acne known as blackheads and whiteheads to inflammatory papules and pustules, or to the most severe acne known as nodules and cysts which can lead to scarring.

With more than 40% of teenagers and a significant percentage of the adult population afflicted, acne is one of the most challenging conditions facing physicians today. Other than Accutane and its numerous, often severe side effects, a few of the options available to physicians were to keep the infection under control, either using medication or blue light irradiation. In both cases, only the symptoms were treated.

Ongoing clinical studies both in Europe and the U.S. suggest that the Aramis Laser treats the source of acne by altering the sebaceous gland. It reduces sebum production and sterilizes the target, clearing acne and minimizing its recurrence. The Aramis also stimulates new collagen production reducing the incidence of acne scarring. Each individual treatment resulted in an approximate 25% improvement with optimal results after four treatments -- each at two-week intervals. Patient satisfaction is high with no evidence of edema or erythema and no pain. Patients also noticed an overall improvement in the appearance of the skin.

The Aramis Laser is currently available in North America by Med-Surge Technologies, exclusive distributor for Quantel Medical. In North America please visit http://www.medsurgetech.com/ , or call 800-787-4417. In rest of world please visit http://www.quantel-medical.fr/ , or call +33 (0)4 73 745 745.

Contacts: International North America Liliane Lefevre Paul Herchman Quantel Medical Med-Surge Technologies +33 (0)4 73 745 745 (972) 720-0425, ext. 222

Quantel Medical; Med-Surge Technologies

CONTACT: International, Liliane Lefevre of Quantel Medical,+33-0-4-73-745-745; or North America, Paul Herchman of Med-Surge Technologies,+1-972-720-0425, ext. 222


Read at BioSpace.com


comments powered by Disqus
   
Acne

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES